Mitchell Liu

SU‐GG‐T‐427: Dose Painting to Combat Tumor Hypoxia While Sparing Urethra in Prostate IMRT: A Biologically‐Based Adaptive Approach Accounting for Setup Uncertainties and Organ Motion

Vitali Moiseenko, J North, Karl Otto, 2008 .

Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve?

Joseph Bucci, Michael McKenzie, Tom Pickles, 2006, International journal of radiation oncology, biology, physics.

Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.

Mitchell Liu, I. Fraser, Mitchell C C Liu, 2018, Annals of translational medicine.

Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.

Howard Pai, Ingrid Spadinger, Stacy Miller, 2009, International journal of radiation oncology, biology, physics.

The Impact of Peer Review of Volume Delineation in Stereotactic Body Radiation Therapy Planning for Primary Lung Cancer: A Multicenter Quality Assurance Study

Jeffrey Cao, Robert Olson, Eric Berthelet, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PTV margin for dose‐escalated radiation therapy of prostate cancer with daily online realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis

Vitali Moiseenko, Mitchell Liu, Mitchell C C Liu, 2006, Journal of applied clinical medical physics.

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Michael Lock, Stewart Gaede, Suresh Senan, 2019, The Lancet.

Quantitative evaluation on the accuracy of image registration methods in SPECT guided radiation therapy for lung cancer patients

Lisa Tang, Ghassan Hamarneh, Anna Celler, 2009 .

A comparison of post-implant US/CT image fusion and MRI/CT image fusion for 125I prostate brachytherapy post implant dosimetry

Ingrid Spadinger, Mitchell Liu, Mira Keyes, 2009 .

Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients.

Howard Pai, Ingrid Spadinger, Ross Halperin, 2012, Brachytherapy.

Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study

Vitali Moiseenko, Eric Berthelet, Mitchell Liu, 2007, Journal of applied clinical medical physics.

Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer

Howard Pai, Ingrid Spadinger, Scott Tyldesley, 2013, Cancer.